Navigation Links
PROTEAN Plus Dodeca Cell, 220-240 V

ProductsPROTEAN Plus Dodeca Cell, 220-240 V
Company Bio-Rad Lab Equipment
Item PROTEAN Plus Dodeca Cell, 220-240 V
Features 
  • Capacity to run 1 to 12 gels, for high-throughput and reproducibility
  • Ceramic cooling core, buffer recirculation pump, and refrigerated circulator that provide efficient cooling for high-resolution results buffer surrounding gels varies by <1C (patent pending)
  • Plate electrodes that create an optimally uniform electrical field to give straight horizontal run results, equal to the PROTEAN II xi cell in performance (patent pending)
  • Ability to accommodate a variety of gel sizes: 18.3 x 19.3 cm, 18.5 x 20 cm, 20 x 20.5 cm or 25 x 20.5 cm (W x L) and from 1.0 mm up to 3.0 mm gel thickness.
  • Precast and handcast gel options
  • Hinged glass plates with integrated spacers that guarantee perfect alignment and eliminate potential current leaks
  • Differential plate heights that facilitate easy IPG strip or tube gel loading; the AnyGel stand accessory can be used to stabilize gels while loading
  • Easy assembly and cleanup via the quick-connect fittings and convenient drain spout
Description The PROTEAN Plus Dodeca cell accommodates up to 12 large slab gels, matching the capacity of first-dimension runs in the PROTEAN IEF system, for high-throughput 2-D applications* in a convenient format. The PROTEAN Plus Dodeca cell's cooling and recirculating capabilities, along with its plate electrodes, allow consistent, high-resolution results. The handcasting system includes the PROTEAN Plus hinged spacer plates, PROTEAN Plus multi-casting chamber, and the Model 495 gradient former.
Info Bio-Rad Lab Equipment
Customer Service: 510-741-5790
Web site: http://www.bio-rad.com/

Related medicine products :

1. Mini-PROTEAN 3 Dodeca Cell
2. PROTEAN Plus Dodeca Cell, 100-120 V
3. Mini-PROTEAN 3 Dodeca Cell With Multi-Casting Chamber
4. Criterion Dodeca Cell
5. Optima L-XP 50 Hz, 220-240 VAC
6. Optima L-XP 60/50 Hz, 220-240 VAC
7. Optima L-90 K Ultracentrifuge 50 Hz, 220-240 VAC
8. Optima L-90 K Ultracentrifuge 60/50 Hz, 220-240 VAC
9. Optima LE-80 K Ultracentrifuges 60/50 Hz, 220-240 VAC
10. Optima LE-80 K Ultracentrifuges 50 Hz, 220-240 VAC
11. Wellwash 4 Mk2 (220-240 V AC/50 Hz)
...l system for hair removal, with scanner and skin c...tion system. The 90W laser generates enough power... bugle. To ease and optimise treament, the laser b...t® 413 scanner.,The laser beam is delivered t...
VERSASTEP™ Reposable Reusable Components (Standard Length).
VersaStep™ Reposable Sterilization Trays.
...use system device is comprised of the following co...access port are also packaged in the following con...ep™ cannula assembly and blunt dilator, pack...m Reposable Step™ valve assembly, packaged s...
Medicine Products:
(Date:9/5/2008)...s the Latest Developments in Molecular,Testing and... /PRNewswire-USNewswire/ -- The practice of,pathol...g and the promise,of personalized medicine will ch...and other imaging technologies will change the way...ogists is taking a leadership role in,making sure ...
(Date:9/5/2008)...RNewswire-USNewswire/ -- The Health Resources,and ... million in grants to,increase and improve medical... grants continue President Bush,s historic expansi...w reach more economically,vulnerable and geographi...dministrator Elizabeth M. Duke said. "In 2007, mor...
(Date:9/5/2008)...tical ,anti-cloak, could bring objects out of hidi...-- Just in case someone develops a cloak of invisi... how to uncloak the objects it hides. , Accordi...in materials underneath an invisibility cloak woul...esearchers at Shanghai Jiao Tong University in Chi...
(Date:9/5/2008)...ain to commit to develop a National AIDS,Strategy ...p. 5 /PRNewswire-USNewswire/ -- The,Republican Nat...ion of the,domestic AIDS epidemic in the United St...erseas. Neither Presidential nominee Sen. John McC... mentioned AIDS in their remarks,to Convention del...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3
...ved breast cancer twice, says that all women deser...at the life-saving and life-improving drug should ...rom this deadly cancer have a chance of successful... uniform policy and the drug is federally funded i...
...obbed off their pockets to pay for expensive anti-... the service based health care system, // believed... AIDS related symptoms when she was admitted to th...e bit of money she had, ensured prompt medical att...
...esia has been confirmed to be bird flu related as ...ncy, according to official sources. // If this wer...ognized testing centers, it would increase the Ind...2. 'We got the local test result around Friday. H...
...of the primary diseases affecting the children bel...asons. RSV infections start by the end of November... the month of December. // Deborah Lehman, MD, ass...diseases and HIV at Cedars-Sinai Medical Center sa...
Other Medicine News:Health News:AIDS Patients Deceived By Private Health Care System In China 2Health News:Parental Knowledge Of RSV Infections Is Vital 2
(Date:9/5/2008)...re-USNewswire/ -- The Florida,Technology, Research...lantic University researcher Dr. Herbert Weissbach...er for Molecular Biology and,Biotechnology in the ...ources LLC (CHS), $184,294 as part of the State Un...nt program (SURECAG). SURECAG was,established by t...
(Date:9/5/2008)...ire-USNewswire/ -- A team of,researchers at West V...from,India and Pakistan take on the habits of thei...ate cancer among male immigrants and breast cancer...er develop due to many reasons, but,environmental ...ancers,",said Jame Abraham, M.D., medical director...
(Date:9/4/2008)...ire-FirstCall/ -- BioForm Medical,Inc. (Nasdaq: ...tudy of,Polidocanol, conducted in Germany by BioFo... Co. GmbH (Kreussler), successfully met the study ...part of a New Drug Application,(NDA) process., In...acy and safety of,Aethoxysklerol compared to Sodiu...
(Date:9/4/2008)...re/ -- Southern Research Institute,today announced...selected,the organization to participate in the ne...nter Network (MLPCN). The MLPCN -- a collaborative...aries Program which is,designed to benefit human h...enome and validate future targets for drug discove...
Breaking Medicine Technology:Major State Grant Accelerates Research and Development of Novel Cancer Therapy 2Major State Grant Accelerates Research and Development of Novel Cancer Therapy 3Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Marijuana withdrawal as bad as withdrawal from cigarettes 10048 1Marijuana withdrawal as bad as withdrawal from cigarettes 10048 2Marijuana withdrawal as bad as withdrawal from cigarettes 10048 3Infection With Common Parasite Raises Schizophrenia Risk 10046 1Infection With Common Parasite Raises Schizophrenia Risk 10046 2United States Gives 2412 Million to Pediatric AIDS Foundation Initiative 10043 1United States Gives 2412 Million to Pediatric AIDS Foundation Initiative 10043 2Arthritic knees remain painful after arthroscopic surgery 10040 1Arthritic knees remain painful after arthroscopic surgery 10040 2Arthritic knees remain painful after arthroscopic surgery 10040 3
...es support the development of DG041 as an,effectiv...sk, REYKJAVIK, Iceland, June 25, 2007 /PRNewswire-...ress in the development of,DG041, the company,s Ph...f arterial thrombosis. The results of the Phase II...y build upon previous,findings demonstrating DG041...
...g,s Efficacy at Improving Glycemic Control and,Red...GO, Ill., June 23, 2007 /PRNewswire/ -- VeroScienc...partner S2 Therapeutics,Inc., reported today the ...g the overall and cardiovascular safety of Cyclose...e mesylate) in subjects,with type 2 diabetes. The ...
Other Medicine Technology:Positive Clinical Results for DG041 Lead Product Development,Highlights at deCODE R&D Event 2Positive Clinical Results for DG041 Lead Product Development,Highlights at deCODE R&D Event 3Positive Clinical Results for DG041 Lead Product Development,Highlights at deCODE R&D Event 4Positive Clinical Results for DG041 Lead Product Development,Highlights at deCODE R&D Event 5Positive Clinical Results for DG041 Lead Product Development,Highlights at deCODE R&D Event 6Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 2Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 3Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 4Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 5